Advanced Search

Pediatric Oncology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Michael Link

    Michael Link

    Division of Hematology, Oncology and Stem Cell Transplantation, Stanford University School of Medicine, Stanford, CA, USA

Section Topics

  • » Acute lymphoblastic leukemia
  • » Biology of leukemia
  • » Biology of solid tumors
  • » Bone tumors
  • » Brain tumors
  • » Epidemiology & etiology
  • » Germ-cell tumors & retinoblastoma
  • » Histiocytosis
  • » Hodgkin's disease
  • » Imaging
  • » Late effects in treatments
  • » Liver tumors
  • » Myelodysplasias
  • » Neuroblastoma & variants
  • » New methodology in surgery & systemic chemotherapy & radiotherapy
  • » Non-Hodgkin's lymphoma
  • » Other rare tumors
  • » Palliative care
  • » Soft tissue sarcoma
  • » Supportive medical care
  • » Supportive pyschosocial care (including complementary medicine)
  • » Tumor pathology
  • » Wilms’ & other kidney tumors

LATEST EVALUATION

We found this article interesting because it establishes a novel method to target myc-driven tumors, which has been somewhat of a holy grail in the field of pediatric cancers. Bill Weiss' group perform an...

John Maris and David Teachey, The Children's Hospital of Philadelphia, USA. F1000 Oncology

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

8
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

Witt H, Mack SC, Ryzhova M, Bender S, ..., Lichter P, Korshunov A, Taylor MD, Pfister SM. Cancer Cell. 2011 Aug 16; 20(2):143-57

1 Evaluation, most recent by

Jan Stary and Michal Zapotocky, University Hospital Motol, Czech Republic. F1000 Hematology

  • New Finding
  • Novel Drug Target

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000